ERK1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility

Author:

de la Fuente‐Vivas Dalia1,Cappitelli Vincenzo1,García‐Gómez Rocío12,Valero‐Díaz Sara1,Amato Camilla1,Rodriguéz Javier3,Duro‐Sánchez Santiago2456ORCID,von Kriegsheim Alexander3,Grusch Michael7ORCID,Lozano José8,Arribas Joaquín2456,Casar Berta12ORCID,Crespo Piero12ORCID

Affiliation:

1. Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC) Consejo Superior de Investigaciones Científicas (CSIC) – Universidad de Cantabria Santander Spain

2. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III Madrid Spain

3. Cancer Research UK Scotland Centre, Institute of Genetics and Cancer University of Edinburgh UK

4. Cancer Research Program Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain

5. Department of Biochemistry and Molecular Biology Universitat Autónoma de Barcelona Spain

6. Preclinical and Translational Research Program Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain

7. Center for Cancer Research Medical University of Vienna Austria

8. Universidad de Málaga and Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina – IBIMA, Plataforma Bionand Spain

Abstract

ERK1/2 mitogen‐activated protein kinases (ERK) are key regulators of basic cellular processes, including proliferation, survival, and migration. Upon phosphorylation, ERK becomes activated and a portion of it dimerizes. The importance of ERK activation in specific cellular events is generally well documented, but the role played by dimerization is largely unknown. Here, we demonstrate that impeding ERK dimerization precludes cellular movement by interfering with the molecular machinery that executes the rearrangements of the actin cytoskeleton. We also show that a constitutively dimeric ERK mutant can drive cell motility per se, demonstrating that ERK dimerization is both necessary and sufficient for inducing cellular migration. Importantly, we unveil that the scaffold protein kinase suppressor of Ras 1 (KSR1) is a critical element for endowing external agonists, acting through tyrosine kinase receptors, with the capacity to induce ERK dimerization and, subsequently, to unleash cellular motion. In agreement, clinical data disclose that high KSR1 expression levels correlate with greater metastatic potential and adverse evolution of mammary tumors. Overall, our results portray both ERK dimerization and KSR1 as essential factors for the regulation of cell motility and mammary tumor dissemination.

Funder

Instituto de Salud Carlos III

Wellcome Trust

Ministerio de Ciencia e Innovación

Fundación Fero

Centro de Investigación Biomédica en Red de Cáncer

Breast Cancer Research Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3